<code id='4E71801811'></code><style id='4E71801811'></style>
    • <acronym id='4E71801811'></acronym>
      <center id='4E71801811'><center id='4E71801811'><tfoot id='4E71801811'></tfoot></center><abbr id='4E71801811'><dir id='4E71801811'><tfoot id='4E71801811'></tfoot><noframes id='4E71801811'>

    • <optgroup id='4E71801811'><strike id='4E71801811'><sup id='4E71801811'></sup></strike><code id='4E71801811'></code></optgroup>
        1. <b id='4E71801811'><label id='4E71801811'><select id='4E71801811'><dt id='4E71801811'><span id='4E71801811'></span></dt></select></label></b><u id='4E71801811'></u>
          <i id='4E71801811'><strike id='4E71801811'><tt id='4E71801811'><pre id='4E71801811'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:17469
          Judge's gavel
          Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

          WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

          Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

          advertisement

          Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more
          Life science postdocs should get big pay hike, NIH panel says
          Life science postdocs should get big pay hike, NIH panel says

          AdobeANationalInstitutesofHealthworkinggrouponFridayrecommendedasizableincreaseinsalariesofpostdocto

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Boston Scientific acquires urology company Axonics for $3.7 billion

          BostonScientificisgrowingitsurologyportfoliowiththeAxonicsacquisition.StevenSenne/APBostonScientific